WHAT IS
TIRZEPATIDE?
A research-focused guide to Tirzepatide, a dual GLP-1 and GIP receptor agonist studied in metabolic research, glucose regulation pathways and appetite signalling models.
Tirzepatide is a synthetic research peptide widely studied for its activity across two incretin receptor pathways: GLP-1 and GIP.
In scientific literature, Tirzepatide is commonly described as a dual receptor agonist because it interacts with both glucagon-like peptide-1 receptors and glucose-dependent insulinotropic polypeptide receptors. This dual mechanism has made it one of the most discussed compounds in metabolic research.
Aminopure supplies Tirzepatide strictly for laboratory research purposes only. It is not supplied for human consumption, personal use, medical use, diagnosis, treatment or prevention of disease.
RESEARCH USE ONLY
Tirzepatide research products sold by Aminopure are intended strictly for laboratory research. They are not medicines, not supplements and not for individual or human use.
HOW DOES TIRZEPATIDE WORK IN RESEARCH?
Tirzepatide is studied because it targets two incretin-related pathways that are involved in glucose regulation, appetite signalling and metabolic response.
GLP-1 Pathway
Researchers study GLP-1 receptor activity for its connection to insulin signalling, satiety response and glucose regulation.
GIP Pathway
GIP receptor research focuses on glucose-dependent insulinotropic signalling and metabolic response mechanisms.
Dual Agonist Research
Tirzepatide is researched as a dual agonist because it interacts with both GLP-1 and GIP receptor pathways.
WHY ARE RESEARCHERS INTERESTED IN TIRZEPATIDE?
Tirzepatide has become a major area of interest in metabolic research because it allows researchers to examine how dual incretin receptor activity may influence metabolic signalling.
Key research areas include glucose regulation, insulin response, appetite signalling, gastric emptying, metabolic efficiency and comparative studies against single-pathway GLP-1 receptor agonists.
AVAILABLE TIRZEPATIDE RESEARCH SIZES
Aminopure offers Tirzepatide in multiple lyophilised research vial sizes for laboratory research customers.
Tirzepatide 10mg
Research vial size for laboratory-based Tirzepatide studies.
Tirzepatide 15mg
Research vial size for metabolic research applications.
Tirzepatide 30mg
Higher research vial size for controlled laboratory use.
Tirzepatide 60mg
Large research vial size for approved research environments.
TIRZEPATIDE VS SEMAGLUTIDE
Semaglutide is generally studied as a GLP-1 receptor agonist, while Tirzepatide is studied as a dual GLP-1 and GIP receptor agonist.
Semaglutide
Studied primarily for GLP-1 receptor activity, including glucose regulation, appetite signalling and metabolic pathway research.
Tirzepatide
Studied for dual GLP-1 and GIP receptor activity, making it a key compound in dual incretin research.
TIRZEPATIDE VS RETATRUTIDE
Tirzepatide and Retatrutide are both studied in advanced metabolic research, but they target different receptor combinations.
Tirzepatide
Dual agonist research compound studied across GLP-1 and GIP receptor pathways.
Retatrutide
Triple agonist research compound studied across GLP-1, GIP and glucagon receptor pathways.
RESEARCH PEPTIDE VS MEDICATION
It is important to separate research-grade Tirzepatide from regulated pharmaceutical medicines. Research peptides are supplied for laboratory research only, while approved medications are prescribed by licensed healthcare professionals and manufactured under pharmaceutical regulations.
Aminopure does not supply Tirzepatide for personal use, medical use or self-administration. All product positioning is strictly research-focused.
FREQUENTLY ASKED QUESTIONS
What is Tirzepatide?
Tirzepatide is a synthetic research peptide studied as a dual GLP-1 and GIP receptor agonist in metabolic research.
Is Tirzepatide a GLP-1 peptide?
Tirzepatide is related to GLP-1 research, but it is more specifically studied as a dual agonist because it targets both GLP-1 and GIP receptor pathways.
Is Tirzepatide the same as Semaglutide?
No. Semaglutide is mainly studied as a GLP-1 receptor agonist, while Tirzepatide is studied as a dual GLP-1 and GIP receptor agonist.
Is Tirzepatide the same as Retatrutide?
No. Tirzepatide is a dual agonist research compound, while Retatrutide is studied as a triple agonist targeting GLP-1, GIP and glucagon receptor pathways.
What strengths of Tirzepatide does Aminopure offer?
Aminopure offers Tirzepatide research vials in 10mg, 15mg, 30mg and 60mg sizes for laboratory research purposes only.
Is Tirzepatide for human use?
No. Aminopure Tirzepatide products are sold strictly for laboratory research purposes only and are not for human consumption, medical use or individual use.
What category does Tirzepatide belong to?
Tirzepatide belongs in the Metabolic Research category because it is studied in relation to GLP-1, GIP, glucose regulation and metabolic pathways.
What is a dual agonist peptide?
A dual agonist peptide is a compound studied for activity across two receptor pathways. Tirzepatide is researched for GLP-1 and GIP receptor activity.
EXPLORE
TIRZEPATIDE RESEARCH
Browse Aminopure’s metabolic research category and explore premium research compounds for laboratory use only.
VIEW METABOLIC RESEARCHResearch Use Only: Aminopure Tirzepatide products are intended strictly for laboratory research purposes only. Not for human consumption, individual use, medical use, diagnosis, treatment or prevention of disease.